Brief: Rosetta Genomics says expect revenue for the second half 2014 to be 40 pct higher vs first half
12/01/2015 13:06
Jan 12 (Reuters) - Rosetta Genomics Ltd ROSG.O : * Says expect revenue for the second half of 2014 to be approximately 40% higher compared with the first half of 2014 * Says on track to launch our microrna-based thyroid neoplasia assay in the third quarter of 2015 * Source text for Eikon ID:nBw4DGjWRa * Further company coverage ROSG.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Rosetta Genomics
See all newsBrief: Interpace Diagnostics Acquires Select Assets Of Rosetta Genomics Out Of Bankruptcy
Brief: Stockholders Approve Genoptix Acquisition Of Rosetta Genomics
Brief: Rosetta Genomics Announces Shareholder Approval Of Merger With Genoptix
Brief: Sabby Management Buys 105,361 ADR Shares Of Rosetta Genomics
Brief: Genoptix Announces Termination Of Merger Agreement With Rosetta Genomics